<DOC>
	<DOCNO>NCT01583023</DOCNO>
	<brief_summary>The purpose study evaluate whether repetitive transcranial magnetic stimulation ( rTMS ) treatment effective adjunct treatment mood stabilizer Bupropion .</brief_summary>
	<brief_title>Using Repetitive Transcranial Magnetic Stimulation ( rTMS ) Treatment Bipolar Depression</brief_title>
	<detailed_description />
	<mesh_term>Depression</mesh_term>
	<mesh_term>Bipolar Disorder</mesh_term>
	<mesh_term>Lithium Carbonate</mesh_term>
	<mesh_term>Bupropion</mesh_term>
	<criteria>BD Type I II subject diagnose accord Diagnostic Statistical Manual Mental Disorders ( DSMIV ) depress phase . Age 18 70 . Rating MontgomeryAsberg Depression Rating Scale ( MADRS ) score &gt; 20 . Rating Beck Depression Inventory ( BDIII ) &gt; 20 . Rating Young Mania Rating Scale ( YMRS ) &lt; 8 . Nontreated new depressive episode , least 2 week duration . If recently start antidepressant Wellbutrin , subject must spend least 4 week therapeutic dose enter study . Lithium epival ( Sodium Valproate ) monotherapy combination . Novel antipsychotic combine mood stabilizer least 4 week steady dosage prior study . History DSMIV Axis I diagnosis BD Type I II Presence psychotic symptom , characterize score 3 item 10 MADRS , score 6 item 9 MADRS , score 6 item 8 YMRS Comorbid active dependence substance abuse ( except nicotine ) Prior electroconvulsive therapy failure Pacemaker , automatic implantable defibrillator implantable pump Aneurysm Clip Heart/Vascular Clip Prosthetic Valve Metal Prosthesis Pregnancy ( must blood Î²HCG test exclude ) Metal metal fragment head Personal Family history seizure disorder Increased Intracranial pressure History stroke , meningitis/encephalitis , moderate severe traumatic brain injury , neurosurgical procedure Pharmacotherapy use substance mention inclusion criterion , except benzodiazepine equivalent dose less equal 1mg/day lorazepam . Failure previous Wellbutrin treatment . Mood disorder secondary medical condition . Subject currently enrol detoxification program</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2014</verification_date>
	<keyword>bipolar disorder</keyword>
	<keyword>repetitive transcranial magnetic stimulation ( rtms )</keyword>
	<keyword>bupropion</keyword>
	<keyword>lithium a/o Epival</keyword>
</DOC>